About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Psoriasis Clinical Trials in Philadelphia | 25 Studies

Clinical Trials PsoriasisPhiladelphia

Psoriasis Clinical Trials in Philadelphia

Find 25 clinical trials for psoriasis near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Psoriasis trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-25 of 25 trials

CompletedPET/CT in Psoriatic ArthritisWhen patients with psoriasis develop joint pain, it is often hard to decide whether or not the pain is due to psoriatic arthritis (PsA).NCT01654198·Philadelphia, Pennsylvania RecruitingGuselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsThe trial is an open-label randomized study that will examine whether switching to a selective IL23 inhibitor (guselkumab) is more effective than switching to a second TNFi…NCT05669833·Loxahatchee Groves, Florida and 13 others CompletedStudy to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to PlaceboTo demonstrate that the efficacy of secukinumab 300 mg at Week 16 was superior to placebo in adult patients with active PsA based on the proportion of patients achieving an…NCT02798211·Birmingham, Alabama and 57 others

Psoriasis Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedComparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to UstekinumabThe aim of this study was to describe the effect of direct IL-17A inhibition with secukinumab as compared with the selective inhibition of IL-23 with guselkumab (p19 subunit…NCT03553823·New Orleans, Louisiana and 13 others

CompletedCOVID-19 VaccinE Response in Rheumatology PatientsThe COVID-19 VaccinE Response in Rheumatology patients (COVER) study is a multicenter randomized controlled trial designed to evaluate the efficacy and safety of a mRNA COVID-19…NCT05080218·Birmingham, Alabama and 7 others

PreviousPage 2 of 2

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia